Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Abdul Majeed, Muhammad Tahir ul Qamar, Arooma Maryam, Muhammad Usman Mirza, Laila Alhussain, Seham Obaid Al Otaibi, Ahmad Almatroudi, Khaled S. Allemailem, Faris Alrumaihi, Abdulaziz A. Aloliqi & Faez Falah Alshehri. (2023) Structural insights into the mechanism of resistance to bicalutamide by the clinical mutations in androgen receptor in chemo-treatment resistant prostate cancer. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-10.
Read now
Read now
Yusuke Ito & Marianne D Sadar. (2018) Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens. Research and Reports in Urology 10, pages 23-32.
Read now
Read now
Michael L Mohler, Vipin A Nair, Dong Jin Hwang, Igor M Rakov, Renukadevi Patil & Duane D Miller. (2005) Nonsteroidal tissue selective androgen receptor modulators: a promising class of clinical candidates. Expert Opinion on Therapeutic Patents 15:11, pages 1565-1585.
Read now
Read now
Articles from other publishers (57)
Federica De Gaetano, Maria Chiara Cristiano, Donatella Paolino, Consuelo Celesti, Daniela Iannazzo, Venerando Pistarà, Nunzio Iraci & Cinzia Anna Ventura. (2022) Bicalutamide Anticancer Activity Enhancement by Formulation of Soluble Inclusion Complexes with Cyclodextrins. Biomolecules 12:11, pages 1716.
Crossref
Crossref
Ioannis Avgeris, Dimanthi Pliatsika, Sotiris S. Nikolaropoulos & Manolis A. Fousteris. (2022) Targeting androgen receptor for prostate cancer therapy: From small molecules to PROTACs. Bioorganic Chemistry 128, pages 106089.
Crossref
Crossref
Amer Jamalpoor, Charlotte AGH van Gelder, Fjodor A Yousef Yengej, Esther A Zaal, Sante P Berlingerio, Koenraad R Veys, Carla Pou Casellas, Koen Voskuil, Khaled Essa, Carola ME Ammerlaan, Laura Rita Rega, Reini EN van der Welle, Marc R Lilien, Maarten B Rookmaaker, Hans Clevers, Judith Klumperman, Elena Levtchenko, Celia R Berkers, Marianne C Verhaar, Maarten Altelaar, Rosalinde Masereeuw & Manoe J Janssen. (2021) Cysteamine–bicalutamide combination therapy corrects proximal tubule phenotype in cystinosis. EMBO Molecular Medicine 13:7.
Crossref
Crossref
Donald J. AbrahamMitchell A. Avery & Amar G. Chittiboyina. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
125
.
Donald J. AbrahamMichael L. Mohler & James T. Dalton. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
103
.
Yuki Ichikawa, Michiaki Hiramatsu, Yusuke Mita, Makoto Makishima, Yotaro Matsumoto, Yui Masumoto, Atsuya Muranaka, Masanobu Uchiyama, Yuichi Hashimoto & Minoru Ishikawa. (2021)
meta
-Non-flat substituents: a novel molecular design to improve aqueous solubility in small molecule drug discovery
. Organic & Biomolecular Chemistry 19:2, pages 446-456.
Crossref
Crossref
Charlene Reyes, Carla Groshel & Robert Given. 2021. Chemotherapy and Immunotherapy in Urologic Oncology. Chemotherapy and Immunotherapy in Urologic Oncology
77
92
.
Zhenyu Yang, Dan Wang, James K. Johnson, Laura E. Pascal, Keita Takubo, Raghunandan Avula, Anish Bhaswanth Chakka, Jianhua Zhou, Wei Chen, Mingming Zhong, Qiong Song, Hui Ding, Zeyu Wu, Uma R. Chandran, Taber S. Maskrey, Joel B. Nelson, Peter Wipf & Zhou Wang. (2020) A Novel Small Molecule Targets Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer. Molecular Cancer Therapeutics 19:1, pages 75-88.
Crossref
Crossref
Alexander A. Korlyukov, Maura Malinska, Anna V. Vologzhanina, Mikhail S. Goizman, Damian Trzybinski & Krzysztof Wozniak. (2020) Charge density view on bicalutamide molecular interactions in the monoclinic polymorph and androgen receptor binding pocket. IUCrJ 7:1, pages 71-82.
Crossref
Crossref
Arwed Cleve & Duy Nguyen. 2018. Successful Drug Discovery. Successful Drug Discovery
95
110
.
Hongli Liu, Rui Han, Jiazhong Li, Huanxiang Liu & Lifang Zheng. (2016) Molecular mechanism of R-bicalutamide switching from androgen receptor antagonist to agonist induced by amino acid mutations using molecular dynamics simulations and free energy calculation. Journal of Computer-Aided Molecular Design 30:12, pages 1189-1200.
Crossref
Crossref
Kyoung-Ah Kim, Yu-Jung Cha, Hae-Mi Lee, Hyun-Jin Joo & Ji-Young Park. (2015) Effects of the ABCG2 and ABCB1 drug transporter polymorphisms on the pharmacokinetics of bicalutamide in humans. Clinica Chimica Acta 438, pages 7-11.
Crossref
Crossref
Jarrad M. Altimari, Birunthi Niranjan, Gail P. Risbridger, Stephanie S. Schweiker, Anna E. Lohning & Luke C. Henderson. (2014) Synthesis and preliminary investigations into novel 1,2,3-triazole-derived androgen receptor antagonists inspired by bicalutamide. Bioorganic & Medicinal Chemistry Letters 24:21, pages 4948-4953.
Crossref
Crossref
Cecilia Fortugno, Greta Varchi, Andrea Guerrini, Pierre-Alain Carrupt & Carlo Bertucci. (2014) Optical biosensor analysis in studying new synthesized bicalutamide analogs binding to androgen receptor. Journal of Pharmaceutical and Biomedical Analysis 95, pages 151-157.
Crossref
Crossref
Laurent Grosse, Anne-Sophie Campeau, Sarah Caron, Frédéric-Alexandre Morin, Kim Meunier, Jocelyn Trottier, Patrick Caron, Mélanie Verreault & Olivier Barbier. (2013) Enantiomer Selective Glucuronidation of the Non-Steroidal Pure Anti-Androgen Bicalutamide by Human Liver and Kidney: Role of the Human UDP-Glucuronosyltransferase (UGT)1A9 Enzyme. Basic & Clinical Pharmacology & Toxicology 113:2, pages 92-102.
Crossref
Crossref
Natalia Mast, Wenchao Zheng, C. David Stout & Irina A. Pikuleva. (2013) Binding of a Cyano- and Fluoro-containing Drug Bicalutamide to Cytochrome P450 46A1. Journal of Biological Chemistry 288:7, pages 4613-4624.
Crossref
Crossref
Devendra K. Dhaked, Vaibhav Jain, Yoganjaneyulu Kasetti & Prasad V. Bharatam. (2012) Conformational polymorphism in bicalutamide: a quantum chemical study. Structural Chemistry 23:6, pages 1857-1866.
Crossref
Crossref
Bernard Haendler & Arwed Cleve. (2012) Recent developments in antiandrogens and selective androgen receptor modulators. Molecular and Cellular Endocrinology 352:1-2, pages 79-91.
Crossref
Crossref
Joel B. Nelson. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
2934
2953.e7
.
Daniel A. von Deutsch, Imad K. Abukhalaf & Rigobert Lapu-Bula. 2012. Handbook of Drug Interactions. Handbook of Drug Interactions
625
754
.
Gopal L. Khatik, Jasmine Kaur, Varun Kumar, Kulbhushan Tikoo, P. Venugopalan & Vipin A. Nair. (2011) Aldol derivatives of Thioxoimidazolidinones as potential anti-prostate cancer agents. European Journal of Medicinal Chemistry 46:8, pages 3291-3301.
Crossref
Crossref
Donald J. AbrahamMitchell A. Avery & Amar G. Chittiboyina. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
35
152
.
Amanda Jones, Dong Jin Hwang, Charles B. DukeIIIIII, Yali He, Anjaiah Siddam, Duane D. Miller & James T. Dalton. (2010) Nonsteroidal Selective Androgen Receptor Modulators Enhance Female Sexual Motivation. Journal of Pharmacology and Experimental Therapeutics 334:2, pages 439-448.
Crossref
Crossref
Howard C. Shen, Mary-Ellen Taplin & Steven P. Balk. 2010. Drug Management of Prostate Cancer. Drug Management of Prostate Cancer
71
81
.
SeungHwan Lee, Yong-Ju Chung, Bo-Hyung Kim, Jun-Hwa Shim, Seo-Hyun Yoon, Sang-Goo Shin, In-Jin Jang & Kyung-Sang Yu. (2009) Comparative pharmacokinetic evaluation of two formulations of bicalutamide 50-mg tablets: An open-label, randomized-sequence, single-dose, two-period crossover study in healthy Korean male volunteers. Clinical Therapeutics 31:12, pages 3000-3008.
Crossref
Crossref
Michael Danquah, Feng Li, Charles B. DukeIIIIII, Duane D. Miller & Ram I. Mahato. (2009) Micellar Delivery of Bicalutamide and Embelin for Treating Prostate Cancer. Pharmaceutical Research 26:9.
Crossref
Crossref
Maria Papaioannou, Sonja Schleich, Ina Prade, Stephanie Degen, Daniela Roell, Undine Schubert, Tamzin Tanner, Frank Claessens, Rudolf Matusch & Aria Baniahmad. (2008) The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth. Journal of Cellular and Molecular Medicine 13:8b, pages 2210-2223.
Crossref
Crossref
Michael L. Mohler, Casey E. Bohl, Amanda Jones, Christopher C. Coss, Ramesh Narayanan, Yali He, Dong Jin Hwang, James T. Dalton & Duane D. Miller. (2009) Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit. Journal of Medicinal Chemistry 52:12, pages 3597-3617.
Crossref
Crossref
Geert J. C. M. Kolvenbag & Barrington J.A. Furr. 2009. Hormone Therapy in Breast and Prostate Cancer. Hormone Therapy in Breast and Prostate Cancer
347
368
.
Casey E. Bohl, Zengru Wu, Jiyun Chen, Michael L. Mohler, Jun Yang, Dong Jin Hwang, Suni Mustafa, Duane D. Miller, Charles E. Bell & James T. Dalton. (2008) Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators. Bioorganic & Medicinal Chemistry Letters 18:20, pages 5567-5570.
Crossref
Crossref
Michael L. Mohler, Casey E. Bohl, Ramesh Narayanan, Yali He, Dong Jin Hwang, James T. Dalton & Duane D. Miller. 2008. Nuclear Receptors as Drug Targets. Nuclear Receptors as Drug Targets
249
304
.
Nima Sharifi, Ernest Hamel, Markus A. Lill, Prabhakar Risbood, Charles T. KaneJr.Jr., Md Tafazzal Hossain, Amanda Jones, James T. Dalton & William L. Farrar. (2007) A bifunctional colchicinoid that binds to the androgen receptor. Molecular Cancer Therapeutics 6:8, pages 2328-2336.
Crossref
Crossref
Xuqing Zhang, Xiaojie Li, George F. Allan, Tifanie Sbriscia, Olivia Linton, Scott G. Lundeen & Zhihua Sui. (2007) Design, Synthesis, and in Vivo SAR of a Novel Series of Pyrazolines as Potent Selective Androgen Receptor Modulators. Journal of Medicinal Chemistry 50:16, pages 3857-3869.
Crossref
Crossref
Ephraim E. Parent, Carmen S. Dence, Carl Jenks, Terry L. Sharp, Michael J. Welch & John A. Katzenellenbogen. (2007)
Synthesis and Biological Evaluation of [
18
F]Bicalutamide, 4-[
76
Br]Bromobicalutamide, and 4-[
76
Br]Bromo-thiobicalutamide as Non-Steroidal Androgens for Prostate Cancer Imaging
. Journal of Medicinal Chemistry 50:5, pages 1028-1040.
Crossref
Crossref
Aya Fujino, Masayoshi Asano, Hitomi Yamaguchi, Naoki Shirasaka, Akiko Sakoda, Masaya Ikunaka, Rika Obata, Shigeru Nishiyama & Takeshi Sugai. (2007) Bacillus subtilis epoxide hydrolase-catalyzed preparation of enantiopure 2-methylpropane-1,2,3-triol monobenzyl ether and its application to expeditious synthesis of (R)-bicalutamide. Tetrahedron Letters 48:6, pages 979-983.
Crossref
Crossref
Wenqing Gao, Zengru Wu, Casey E. Bohl, Jun Yang, Duane D. Miller & James T. Dalton. (2006) CHARACTERIZATION OF THE IN VITRO METABOLISM OF SELECTIVE ANDROGEN RECEPTOR MODULATOR USING HUMAN, RAT, AND DOG LIVER ENZYME PREPARATIONS. Drug Metabolism and Disposition 34:2, pages 243-253.
Crossref
Crossref
Mireille Cantarini, Rainard Fuhr & Thomas Morris. (2006) Pharmacokinetics of Two Novel Bicalutamide Formulations in Healthy Male Volunteers. Pharmacology 77:4, pages 171-178.
Crossref
Crossref
Raj Betageri, Yan Zhang, Renee M. Zindell, Daniel Kuzmich, Thomas M. Kirrane, Jörg Bentzien, Mario Cardozo, Alison J. Capolino, Tazmeen N. Fadra, Richard M. Nelson, Zofia Paw, Daw-Tsun Shih, Cheng-Kon Shih, Ljiljana Zuvela-Jelaska, Gerald Nabozny & David S. Thomson. (2005) Trifluoromethyl group as a pharmacophore: Effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand. Bioorganic & Medicinal Chemistry Letters 15:21, pages 4761-4769.
Crossref
Crossref
Juhyun Kim, Di Wu, Dong Jin Hwang, Duane D. Miller & James T. Dalton. (2005)
The
Para
Substituent of
S
-3-(Phenoxy)-2-hydroxy-2-methyl-
N
-(4-nitro-3-trifluoromethyl-phenyl)-propionamides Is a Major Structural Determinant of in Vivo Disposition and Activity of Selective Androgen Receptor Modulators
. Journal of Pharmacology and Experimental Therapeutics 315:1, pages 230-239.
Crossref
Crossref
Casey E. Bohl, Wenqing Gao, Duane D. Miller, Charles E. Bell & James T. Dalton. (2005) Structural basis for antagonism and resistance of bicalutamide in prostate cancer. Proceedings of the National Academy of Sciences 102:17, pages 6201-6206.
Crossref
Crossref
Jiyun Chen, Dong Jin Hwang, Casey E. Bohl, Duane D. Miller & James T. Dalton. (2005) A Selective Androgen Receptor Modulator for Hormonal Male Contraception. Journal of Pharmacology and Experimental Therapeutics 312:2, pages 546-553.
Crossref
Crossref
Craig A. Marhefka, Wenqing Gao, Kiwon Chung, Juhyun Kim, Yali He, Donghua Yin, Casey Bohl, James T. Dalton & Duane D. Miller. (2004) Design, Synthesis, and Biological Characterization of Metabolically Stable Selective Androgen Receptor Modulators. Journal of Medicinal Chemistry 47:4, pages 993-998.
Crossref
Crossref
Ian D Cockshott. (2004) Bicalutamide. Clinical Pharmacokinetics 43:13, pages 855-878.
Crossref
Crossref
Daniel A. von Deutsch, Imad K. Abukhalaf & Robin R. Socci. 2004. Handbook of Drug Interactions. Handbook of Drug Interactions
493
596
.
Donghua Yin, Wenqing Gao, Jeffrey D. Kearbey, Huiping Xu, Kiwon Chung, Yali He, Craig A. Marhefka, Karen A. Veverka, Duane D. Miller & James T. Dalton. (2003) Pharmacodynamics of Selective Androgen Receptor Modulators. Journal of Pharmacology and Experimental Therapeutics 304:3, pages 1334-1340.
Crossref
Crossref
Donghua Yin, Huiping Xu, Yali He, Leonid I. Kirkovsky, Duane D. Miller & James T. Dalton. (2003) Pharmacology, Pharmacokinetics, and Metabolism of Acetothiolutamide, a Novel Nonsteroidal Agonist for the Androgen Receptor. Journal of Pharmacology and Experimental Therapeutics 304:3, pages 1323-1333.
Crossref
Crossref
Donghua Yin, Yali He, Minoli A. Perera, Seoung Soo Hong, Craig Marhefka, Nina Stourman, Leonid Kirkovsky, Duane D. Miller & James T. Dalton. (2003) Key Structural Features of Nonsteroidal Ligands for Binding and Activation of the Androgen Receptor. Molecular Pharmacology 63:1, pages 211-223.
Crossref
Crossref
Yali He, Donghua Yin, Minoli Perera, Leonid Kirkovsky, Nina Stourman, Wei Li, James T Dalton & Duane D Miller. (2002) Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor. European Journal of Medicinal Chemistry 37:8, pages 619-634.
Crossref
Crossref
Kenneth D James & Nnochiri N Ekwuribe. (2002) Syntheses of enantiomerically pure (R)- and (S)-bicalutamide. Tetrahedron 58:29, pages 5905-5908.
Crossref
Crossref
Toshiyasu Ishioka, Asako Kubo, Yukiko Koiso, Kazuo Nagasawa, Akiko Itai & Yuichi Hashimoto. (2002) Novel Non-Steroidal/Non-Anilide Type Androgen Antagonists with an Isoxazolone Moiety. Bioorganic & Medicinal Chemistry 10:5, pages 1555-1566.
Crossref
Crossref
Zixin Zhu, Oleg V. Bulgakov, Stephanie S. Scott & James T. Dalton. (2001) Recombinant Expression and Purification of Human Androgen Receptor in a Baculovirus System. Biochemical and Biophysical Research Communications 284:3, pages 828-835.
Crossref
Crossref
Craig A. Marhefka, Bob M. Moore, Thomas C. Bishop, Leonid Kirkovsky, Arnab Mukherjee, James T. Dalton & Duane D. Miller. (2001) Homology Modeling Using Multiple Molecular Dynamics Simulations and Docking Studies of the Human Androgen Receptor Ligand Binding Domain Bound to Testosterone and Nonsteroidal Ligands. Journal of Medicinal Chemistry 44:11, pages 1729-1740.
Crossref
Crossref
Lin Zhi & Esther Martinborough. 2001.
169
180
.
Leonid Kirkovsky, Arnab Mukherjee, Donghua Yin, James T. Dalton & Duane D. Miller. (2000) Chiral Nonsteroidal Affinity Ligands for the Androgen Receptor. 1. Bicalutamide Analogues Bearing Electrophilic Groups in the B Aromatic Ring. Journal of Medicinal Chemistry 43:4, pages 581-590.
Crossref
Crossref
Arnab Mukherjee, Leonid I. Kirkovsky, Yasuhiro Kimura, Michele M. Marvel, Duane D. Miller & James T. Dalton. (1999) Affinity labeling of the androgen receptor with nonsteroidal chemoaffinity ligands. Biochemical Pharmacology 58:8, pages 1259-1267.
Crossref
Crossref
James T. Dalton, Arnab Mukherjee, Zixin Zhu, Leonid Kirkovsky & Duane D. Miller. (1998) Discovery of Nonsteroidal Androgens. Biochemical and Biophysical Research Communications 244:1, pages 1-4.
Crossref
Crossref
Richard L. Tolman, Soumya P. Sahoo, Raman K. Bakshi, Dominick Gratale, Gool Patel, Sushma Patel, Jeffrey Toney, Benedict Chang & Georgianna S. Harris. (1997) 4-Methyl-3-oxo-4-aza-5?-androst-1-ene-17?-N-aryl-carboxamides: an approach to combined androgen blockade [5?-reductase inhibition with androgen receptor binding in vitro]. The Journal of Steroid Biochemistry and Molecular Biology 60:5-6, pages 303-309.
Crossref
Crossref